Valentina Fabrizio

Valentina Fabrizio


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2026 in Journal of Nuclear Engineering
Verified
Journal Article
Open access
PDF file
LSLucrezia Spagnuolo
Lucrezia Spagnuolo
Luigi LeporeLuigi Lepore
Luigi Lepore
SPSimone Placidi
Simone Placidi
FLFrancesca Limosani
Francesca Limosani
APAngela Pagano
Angela Pagano
Marco CapogniMarco Capogni
Marco Capogni
The global demand for medical radionuclides is rapidly increasing, driven by the expansion of diagnostic and therapeutic radiopharmaceuticals, and by recurrent vulnerabilities in international supply chains. While high-flux reactors remain the backbone of large-scale isotope production, low- and medium-power research reactors—such as TRIGA facilities—offer valuable opportunities for decentralised, flexible, and alternative radionuclide generation. Several studies have demonstrated their capability to produce emerging therapeutic or diagnostic isotopes, including 111Ag, 99Mo/99mTc, 64Cu, 177Lu, and 161Tb, although with yield limitations inherent to moderate neutron flux levels. In Europe, recent initiatives such as PRISMAP, SIMPLERAD, and SECURE aim to strengthen production capacity and diversify radionuclide availability. Within this framework, Italy—lacking operational power reactors—seeks alternative routes to ensure a resilient national supply. This work presents the investigation carried out within the SECURE project to assess the feasibility of an Italian production cycle for medical-grade 161Tb at the ENEA TRIGA RC-1 Research Reactor (Rome). The study integrates reactor-specific irradiation analyses, the development of chemical separation and target recovery processes, and a comprehensive economic evaluation within a full lifecycle perspective. The results highlight the potential and constraints of a TRIGA-based production for supporting future Italian theranostic needs.

16 November 2023 in The European Physical Journal Plus
Verified
Journal Article
Open access
PDF file
LSLuciano Sperandio
Luciano Sperandio
Luigi LeporeLuigi Lepore
Luigi Lepore
EBEnrico Maria Borra
Enrico Maria Borra
Luca CicianiLuca Ciciani
Luca Ciciani
VFValentina Fabrizio
Valentina Fabrizio
IVIgnazio Vilardi
Ignazio Vilardi
The nuclear facility TRIGA RC-1 is located at the ENEA Casaccia Research Center in Rome. It is a thermal spectrum research reactor with a thermal power of 1 MW and a Mark III containment. The failure of the fuel cladding of the General Atomic TRIGA is a well-known phenomenon in the literature and is normally expected during its lifetime. Depending on the severity of the cracking, this results in the transfer of radioactivity from inside the fuel rods to the demineralized moderation and cooling water of the primary circuit. This occurs especially when the fuel is heated, as the temperature rise leads to an increase in the internal pressure inside the rods, causing fission products, especially gaseous ones, to be released through the cracks. The sustained release of these fission products over time causes impurities with longer half-lives (e.g., Cs-137) to accumulate in the primary water purification system and, in particular, in the ion exchange resin tank. Therefore, the detection of Cs-137 in the ion exchange resins of the primary water purification system of the reactor is a sufficiently clear indication of the occurrence of such disturbances. Indeed, Cs-137 is not only a direct fission product of U-235, but is also produced by the decay of Xe-137 (one of the major fission noble gasses), which, because of its physical nature, readily escapes through the rod cladding. To ensure worker protection from ionizing radiation during the identification and replacement of defective fuel rods, a special program of physical, environmental, and personal radiation protection monitoring was conducted. In addition to a brief description of the work performed, this report presents the results of radiometric measurements and associated individual dose assessment performed before, during, and after the identification and replacement of the defected fuel elements.